Wang Md tag sponsored by:
Wang Md
-
CML-400 Olverembatinib (HQP1351) Overcomes Ponatinib and / or Asciminib Resistance in Patients With Heavily Pretreated / Refractory Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
mastopedia.wordpress.com | | Article Details | Related Articles